FORM OF EXCHANGE AGREEMENTExchange Agreement • June 29th, 2023 • Origin Life Sciences, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
This Exchange Agreement (this “Agreement”), dated as of June [ ], 2023, is made by and between Origin Life Sciences, Inc., a Delaware corporation (the “Company”), and David Dantzker, as the holder of the Debt (as defined below) (the “Holder” and, together with the Company, the “Parties” and each individually a “Party”).
FORM OF SUBSCRIPTION AGREEMENT (Pre-IPO Round)Subscription Agreement • June 29th, 2023 • Origin Life Sciences, Inc. • Electromedical & electrotherapeutic apparatus
THIS SUBSCRIPTION AGREEMENT (this “Agreement”), is dated as of the last date appearing on the signature pages hereto, is made and entered into by and between Origin Life Sciences, Inc., a Delaware corporation (the “Company”), and the individual or entity signatory hereto (“Subscriber”).
FORM OF COMMON STOCK PURCHASE WARRANT ORIGIN LIFE SCIENCES, INC.Security Agreement • June 29th, 2023 • Origin Life Sciences, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________________ or any registered assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time following the Issue Date (the “Initial Exercise Date”) and on or prior to the close of business on _______________, 20301 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Origin Life Sciences, Inc., a Delaware corporation (the “Company”), up to _____________ shares of Common Stock (the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
